2020 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y12 Receptor Antagonists in the Asia-Pacific Region

The unique characteristics of patients with acute coronary syndrome in the Asia-Pacific region mean that international guidelines on the use of dual antiplatelet therapy (DAPT) cannot be routinely applied to these populations. Newer generation P2Y12 inhibitors (i.e. ticagrelor and prasugrel) have de...

Full description

Bibliographic Details
Main Authors: Jack WC Tan, Derek P Chew, Muhamad Ali SK Abdul Kader, Junya Ako, Vinay K Bahl, Mark Chan, Kyung Woo Park, Praveen Chandra, I-Chang Hsieh, Do Quang Huan, Sofian Johar, Dafsah Arifa Juzar, Byeong-Keuk Kim, Cheol Whan Lee, Michael Kang-Yin Lee, Yi-Heng Li, Wael Almahmeed, Eric Oliver Sison, Doreen Tan, Yu-Chen Wang, Shiuan Jong Yeh, Gilles Montalescot
Format: Article
Language:English
Published: Radcliffe Medical Media 2021-03-01
Series:European Cardiology Review
Online Access:https://www.ecrjournal.com/articleindex/ecr.2020.40